Tag Archives: media

Quebec emergency room doctors warn conditions out of control due to surge of COVID and other respiratory infections – WSWS

With the onset of winter, Quebecs emergency rooms are overflowing, endangering the health and lives of Quebecers. A major driver of the increased burden on hospitals is a surge in COVID-19 cases.

This is a repeat of the situation experienced in November and December 2022. According to the governments Index Sant website, the provinces overall emergency-room (ER) occupancy rate has exceeded 100 percent on every single day since Nov. 12. On Tuesday, the average rate across the province was 131 percent. In Laval, Quebecs third-largest city, it was 182 percent and in the nearby Lanaudire region, 171 per cent.

ER doctors wrote to Health Minister Christian Dub last Friday to warn that conditions in emergency rooms across the province are out of control. Overcrowding in the emergency department leads to daily mortality, says the letter, which was written by Dr. Marie-Maud Couture, the president of the Regroupement des Chefs dUrgence du Qubec (Association of Emergency Rooms Chiefs), and supported by the hundreds of doctors and residents who comprise the Association des spcialistes en mdecine durgence du Qubec(Quebec Association of Specialists in Emergency Medicine).

Congestion in emergency departments leads to mortality, recently estimated at one excess death for every 82 patients admitted, wrote Dr. Couture. This statistic does not take into account indirect deaths, i.e. people who present late despite having an urgent medical condition, for fear of waiting more than 24 hours in a waiting room, and sometimes even for fear of being a nuisance.

The immediate cause of the current overcrowding crisis is the triple epidemic of respiratory viruses that is hitting the province. As in 2022, influenza, COVID-19 and respiratory syncytial virus (RSV) are infecting Quebecers en masse.

According to the Institut national de sant publique du Qubec (INSPQ), some 130,000 Quebecers contract a respiratory virus every day.

COVID-19 is believed to be responsible for a third of these infections, although official figures (4,987 new cases for the week ending November 26) continue to seriously underestimate the number of cases. This is because they are based on PCR tests, which are accessible to only a small minority of people. These incomplete official figures and voluntary declarations of positive rapid tests have been steadily increasing since the end of September.

As of last week, 2,200 people were hospitalized with COVID-19, a number that exceeds what was seen in 2020 and 2021 before the arrival of the Omicron wave. This shows that the policy of mass infection adopted by the ruling class at the time has allowed the disease to take hold permanently, with a very high baseline.

COVID-19 also continues to kill. The 70 people who died between November 26 and December 2 in Quebec brought the official count of COVID deaths since 2020 to 19,084. At the end of November, Statistics Canada published its annual report on life expectancy in Canada. For the third year in a row, life expectancy in the country has fallen, from 82.3 years in 2019 to 81.3 in 2022.

The Statscan report also revealed that COVID-19 caused more deaths in the country last year than in any other year of the pandemic. With over 19,700 deaths attributable to it in 2022, COVID-19 is now the third leading cause of death in the country, responsible for around 6 percent of all deaths. In Quebec and Ontario, the two most populous provinces, mortality caused by COVID-19 increased by 38 percent in 2022 as compared to 2021.

The right-wing Coalition avenir Qubec (CAQ) government, with the complicity of the corporate-controlled media outlets and the federal Liberal government, is doing everything in its power to prevent the public from becoming aware of the immense dangers it faces. Its aim is to continue pursuing a deliberate policy of mass infection.

The COVID-19 health emergency was lifted in Quebec on June 1, 2022, and all measures, including the mandatory wearing of masks in healthcare centers, were eliminated. Even tracking the evolution of COVID-19 has become almost impossible due to the lack of data.

In the most recent example, on December 6 the INSPQ discreetly announced on its website that data on hospitalizations linked to COVID had also become imprecise with the end of the obligation for hospitals to record specific information. In particular, it will no longer be possible to know the number of COVID patients hospitalized in intensive care units.

Government and media propaganda downplaying the dangers associated with COVID has also led to a collapse in the number of Quebecers keeping their COVID vaccinations up to date. As of the middle of December, barely 900,000 people, or around 14 percent of the population, had received a booster dose designed to combat the Omicron XBB.1.5 sub-variant since the vaccination campaign began in October.

The data are just as alarming for the most vulnerable people, the only ones for whom the government and INSPQ officially recommend the vaccine. Vaccination rates are 39.1 percent for those over 60 and 45.8 percent for people aged 70-79. Of those 80 and over barely half, 50.5 percent, have received the latest booster.

Quebec Public Health Director Dr. Luc Boileau has warned of a cocktail of COVID-19 and flu for Christmas, even while downplaying the dangers. He is urging those over 70 to get vaccinated, and recommends that those with symptoms wash their hands and wear a mask. Quebec Premier Franois Legault appointed Boileau as the provinces interim public health director in Jan. 2022, as the government was moving to eliminate all mitigation measures amid the Omicron wave, and later made his posting permanent, precisely because of Boileaus readiness to implement the governments murderous profits-before-lives pandemic policy.

Mehring Books

COVID, Capitalism, and Class War: A Social and Political Chronology of the Pandemic

A compilation of the World Socialist Web Site's coverage of this global crisis, available in epub and print formats.

According to Dr. Boileau, cases of influenzawhose main strain this year is H1N1, which is particularly dangerous for childrenare also rising sharply in Quebec. The test positivity rate has risen from 3.9 percent to almost 7.3 percent in the space of a week, and several adults with influenza are hospitalized in intensive care. Authorities fear that the situation will evolve in the same way as in Alberta, where the test positivity rate has risen from 3 percent to 33 percent in the space of a month.

The deeper causes of the ongoing crisis in emergency departments and, more generally, in the healthcare system, are also well known. They include the savage cuts made for decades by successive Parti Qubcois and Quebec Liberal Party governments, and the intensification of capitalist austerity by the CAQ, which announced in its March budget an increase in healthcare spending below inflation when non-recurring, COVID-19-related expenses are deducted.

Meanwhile, Dubs solutions to the ER crisis are collapsing miserably one after the other. At the end of November, the only two full-time nurses in the first Specialized Nurse Practitioner (SNP) clinic resigned, citing issues impacting the quality and safety of care, including a lack of equipment.

The clinic was opened with great fanfare at the suggestion of the crisis unit set up by Dub in December 2022, when emergency departments were in acute crisis. It was intended to relieve emergency departments and hospitals by treating less urgent cases.

Similarly, the Info-Sant line (811), where sick people are supposed to be able to talk to a professional and be directed to an alternative to ER care if their case is not too serious, is itself overwhelmed. People sometimes have to wait several hours to talk to someone.

In the first week of December, 42.3 percent of 811 callers hung up before getting any advice. Despite this, Dub reiterated on Tuesday that people should avoid the ER if at all possible, encouraging sick people to self-diagnose the severity of their illness and decide if they have the right to seek ER treatment.

The crisis in the healthcare system and the indifference of the ruling class are a serious threat to the lives of Quebecers. Recently, the media revealed that two people died in the emergency room of the Anna-Laberge hospital in Chteauguay, near Montreal, on November 29 and 30.

Although the authorities have refused to give details of these tragic incidents on the pretext that administrative investigations are underway, it appears that one person died after waiting 12 hours, although he was supposed to see a doctor within 30 minutes of arrival according to the preliminary examination carried out in triage. The stretcher occupancy rate at Anna-Laberge Hospital was 184 percent.

Join the fight to end the COVID-19 pandemic

Someone from the Socialist Equality Party or the WSWS in your region will contact you promptly.

See more here:

Quebec emergency room doctors warn conditions out of control due to surge of COVID and other respiratory infections - WSWS

Flagship Pioneering Unveils Quotient Therapeutics to Create … – PR Newswire

Quotient's Somatic Genomics platform reveals new approaches to treat disease based on the vast genetic variation present in the body's trillions of cells

Company emerges from stealth after two years of platform development with an initial commitment of $50 million from Flagship Pioneering

CAMBRIDGE, Mass., Nov. 21, 2023 /PRNewswire/ -- Flagship Pioneering, thebioplatform innovation company, today unveiled Quotient Therapeutics, a company pioneering somatic genomics, the study of genetic variation at the cellular level, to discover therapeutics informed by new links between genes and disease. Flagship has made an initial commitment of $50 million to advance development of the company's platform following two years of development at Flagship Labs and pursue a pipeline of medicines across a wide range of therapeutic areas and modalities.

"The assumption that we each have a single genome turns out to be off by a trillion-fold," said Geoffrey von Maltzahn, Ph.D., Co-Founder and Chief Executive Officer of Quotient Therapeutics and General Partner, Flagship Pioneering. "All cells accumulate random genetic changes in their DNA, resulting in trillions of unique genomes in the body. Some genetic changes make a cell resistant or vulnerable to disease, while others can cause disease. We started Quotient to study the natural genetics library inside every tissue, discover gene variants that are beneficial, neutral, or disease-causing, and to harness that knowledge to develop the medicines of tomorrow."

Quotient's Somatic Genomics platform utilizes proprietary single molecule, genome sequencing technology to reveal the extensive variation encoded in the somatic genome at unprecedented resolution. Created by Flagship scientists in partnership with leading geneticists at the Wellcome Sanger Institute and the University of Texas Southwestern, this platform is able to study natural selection at the cellular level through four steps: phenotyping of cells from clinical tissue samples, isolation, single cell genotyping, and computation. As a result, naturally selected genes, proteins, and pathways are identified as prospective targets for the development of transformative therapies intended to cure, prevent, or reverse disease. Quotient's approach will enable the development of first-in-class drugs across a broad range of modalities and therapeutic areas, including immune disease, cardiometabolic disease, infectious disease, oncology, neurodegenerative disease, rare disease, and aging.

Jacob Rubens, Ph.D., Co-Founder and President of Quotient Therapeutics and Origination Partner, Flagship Pioneering added, "At Quotient, we're inspired by the maxim that 'Nothing in biology makes sense except in the light of evolution.' Our Somatic Genomics platform measures genetic changes underlying the evolution of cells in the body to make sense of disease, illuminating the path to a wide range of potentially curative medicines. Already, we've created the world's largest somatic genomes dataset, demonstrated the applicability of our platform to multiple therapeutic areas, and translated our genetic discoveries into drug discoveries."

Noubar Afeyan, Ph.D., Founder and CEO, Flagship Pioneering and Co-Founder and Strategic Oversight Board Chairman, Quotient Therapeutics, remarked, "One of the defining characteristics of the modern era of genetics has been the systematic comparison of people's genomes. Today, we stand at the precipice of a new era, enabled by the comparison of the trillions of genomes inside each one of us. Genetics has already created tremendous advances in human health, and Quotient is pioneering the next big leap forward."

Academic co-founders of Quotient include Professor Sir Mike Stratton, MD, PhD, Inigo Martincorena, PhD, and Peter Campbell, PhD, from the Wellcome Sanger Institute, and Hao Zhu, MD, from University of Texas Southwestern. In addition to von Maltzahn and Rubens, Quotient is led by Scott Hayton, Ph.D., Acting Chief Operating Officer, Caroline Fox,M.D., MPH, Senior Vice President, Head of Genetics and Target Discovery, and SimonBrunner, Ph.D., Co-Founder and Head of Platform. Quotient is co-located in Cambridge, MA and Cambridge, UK with research facilities in both cities.

To learn more about Quotient Therapeutics visit http://www.quotient-tx.com.

About Quotient Therapeutics

Quotient Therapeutics is the first company to systematically study the genetic variation and evolution of the trillions of cells inside the human body. The company's Somatic Genomics platform reveals novel links between genes and disease across a broad range of therapeutic areas, enabling the discovery of transformative medicines intended to cure, prevent, or reverse disease. Founded by Flagship Pioneering in 2022, Quotient is backed by experts in the field of somatic genetics.

About Flagship Pioneering

Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. To date, Flagship has deployed over $3.4 billion in capital toward the founding and growth of its pioneering companies alongside more than $26 billion of follow-on investments from other institutions. The current Flagship ecosystem comprises 41 companies, including Denali Therapeutics(NASDAQ: DNLI),Foghorn Therapeutics(NASDAQ: FHTX),Generate:Biomedicines,Inari,Indigo Agriculture,Moderna(NASDAQ: MRNA),Omega Therapeutics(NASDAQ: OMGA),Sana Biotechnology(NASDAQ: SANA),Seres Therapeutics(NASDAQ: MCRB) andTessera Therapeutics.

Media Contact:[emailprotected]

SOURCE Flagship Pioneering

Visit link:
Flagship Pioneering Unveils Quotient Therapeutics to Create ... - PR Newswire

10x Genomics Wins Another Patent Infringement Case Against … – PR Newswire

Jury Awards 10x Genomics Over $31 Million in Damages and Finds All Seven Asserted Patents Valid and Willfully Infringed by NanoString

GeoMx Decision is Third Ruling Against NanoString, Showing Serial Infringement of 10x Patents

PLEASANTON, Calif., Nov. 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that a jury in the U.S. District Court for the District of Delaware has reached a unanimous verdict in favor of 10x Genomics in the patent infringement suit 10x filed against the GeoMx products sold by NanoString Technologies, Inc. (Nasdaq: NSTG). In awarding over $31 million in damages, the jury found that NanoString's GeoMx Digital Spatial Profiler and associated instruments, reagents and services for RNA and protein detection willfully infringe all seven asserted patents owned by Prognosys and exclusively licensed to 10x Genomics.

The jury awarded over $31 million in damages for sales of the infringing GeoMx products from May 6, 2021 through October 13, 2023. In post-trial proceedings, 10x intends to seek (a) ongoing royalties for NanoString's willful infringement by sales of the GeoMx products after October 13, 2023; (b) treble damages and attorney's fees for NanoString's willful infringement; (c) a permanent injunction barring the making, using, selling and offering for sale the GeoMx products in the United States; and (d) pre- and post-judgment interest.

"In the last six months, three separate courts have found that both NanoString's CosMx and GeoMx products infringe nine separate 10x patents," said Eric Whitaker, Chief Legal Officer at 10x Genomics. "At some point, NanoString must drop the charade that it is 'confident' it does not infringe the 10x patents and the patents are invalid. It is essential that 10x protect our patents from those who wrongly and willfully use them so we can advance our mission and continue to innovate and push science forward. We are thankful for the jury's careful attention to the extensive evidence presented in this case and their diligence in recognizing 10x's decade-long investment in innovation."

The jury heard testimony from the sole inventor of the patents, Illumina co-founder Mark Chee, and NanoString CEO Brad Gray and NanoString CSO Joe Beechem. After hearing all of the evidence, the jury confirmed that all seven of 10x's asserted patents had been infringed by NanoString, that each of 10x's seven patents was valid, that NanoString willfully infringed those patents and that monetary damages were owed to 10x for the infringement of all seven patents. For a patent to be willfully infringed, the jury had to find that NanoString acted in reckless disregard of 10x's rights, supported by evidence that NanoString acted maliciously, deliberately or in bad faith.

The asserted patents in Case No. 21-cv-653-MFK include (a) U.S. Patent No. 10,472,669; (b) U.S. Patent No. 10,961,566; (c) U.S. Patent No. 10,983,113; (d) U.S. Patent No. 10,996,219; (e) U.S. Patent No. 11,001,878; (f) U.S. Patent No. 11,008,607 and (g) U.S. Patent No. 11,293,917.

This ruling is the third time that NanoString has been found to infringe 10x patents in the past six months. Earlier this year, the European Unified Patent Court (the "UPC") and the Munich Regional Court each ruled that NanoString is infringing 10x Genomics patents and issued injunctions on NanoString's infringing CosMx Spatial Molecular Imager instruments as well as CosMx reagents for RNA detection.

Related Litigation10x has a separate suit pending against NanoString in the U.S. District Court for the District of Delaware alleging that NanoString's CosMx Spatial Molecular Imager and associated instruments, reagents and services infringe multiple patents. The patents asserted in the second U.S. suit against NanoString include (a) U.S. Patent No. 10,227,639; (b) U.S. Patent No. 11,021,737; (c) U.S. Patent No. 11,293,051; (d) U.S. Patent No. 11,293,052; (e) U.S. Patent No. 11,293,054 and (f) U.S. Patent No. 11,542,554. Trial is scheduled for September 2024.

About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. All statements, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "might," "will," "should," "expect," "plan," "anticipate," "could," "intend," "target," "project," "contemplate," "believe," "estimate," "predict," "potential," "would," "likely," "seek" or "continue" or the negatives of these terms or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding 10x Genomics, Inc.'s expectations regarding litigation and remedies as well as possible outcomes of litigation. These statements are based on management's current expectations, forecasts, beliefs, assumptions and information currently available to management, and actual outcomes and results could differ materially from these statements due to a number of factors. The material risks and uncertainties that could affect 10x Genomics, Inc.'s financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" and elsewhere in the documents 10x Genomics, Inc. files with the Securities and Exchange Commission from time to time.

Although 10x Genomics, Inc. believes that the expectations reflected in the forward-looking statements are reasonable, it cannot provide any assurance that these expectations will prove to be correct nor can it guarantee that the future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or occur. These forward-looking statements do not reflect that our success will depend on our ability to obtain, maintain and protect our intellectual property rights, intellectual property litigation could be expensive, time-consuming, unsuccessful and could interfere with our ability to develop, manufacture and commercialize our products or technologies, litigation outcomes are unpredictable or there may be changes in our litigation strategy. The forward-looking statements in this press release are based on information available to 10x Genomics, Inc. as of the date hereof, and 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release.

Disclosure Information10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

ContactsInvestors: [emailprotected] Media: [emailprotected]

SOURCE 10x Genomics, Inc

See the original post:

10x Genomics Wins Another Patent Infringement Case Against ... - PR Newswire

Schworer Earns the American Lung Association/AAAI Allergic … – UNC Health and UNC School of Medicine

Stephen Schworer, MD, PhD, will use the award to better understand the biology of small airways disease in asthma and provide a foundation for mechanistic studies that will inform new therapeutic targets for the condition.

More than 1.4 million people in North Carolina live with lung disease, and each year, millions of people are impacted by respiratory viruses like COVID-19 and influenza. In an effort to advance todays science to end lung disease tomorrow, the American Lung Association Research Institute has awarded $13.6 million in research grants, funding 129 innovative projects across the United States.

Stephen Schworer, MD, PhD, assistant professor of medicine at the UNC School of Medicine, was awarded the American Lung Association/AAAI Allergic Respiratory Diseases Research Award to better understand the biology of small airways disease in asthma and provide a foundation for mechanistic studies that will inform new therapeutic targets for the condition. The award will provide his lab with $75,000 per year for 2 years.

Schworers research will focus on asthma, specifically two features of the disease that could be targets for future treatments: blockages in the lungs airways caused by mucus and changes in the small airways themselves.

By studying the lungs of people who have died from asthma and people with severe asthma, he will investigate the relationship between airways epithelial cells and mucus production, potentially understanding how these genes are turned on and off.

Funding from the Allergic Respiratory Diseases Award is crucial to my work on two understudied and important features of asthma: mucus plugging and small airways disease, said Schworer. This opportunity allows me as an allergist physician-scientist to work with pulmonologists and pathologists to use cutting edge methods to study the molecular features of steroid-refractory severe asthma and fatal asthma.

About the American Lung Association

The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through education, advocacy and research. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to champion clean air for all; to improve the quality of life for those with lung disease and their families; and to create a tobacco-free future. For more information about the American Lung Association, which has a 4-star rating from Charity Navigator and is a Platinum-Level GuideStar Member, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.

Media contact:Kendall Daniels, Communications Specialist, UNC Health | UNC School of Medicine

The rest is here:

Schworer Earns the American Lung Association/AAAI Allergic ... - UNC Health and UNC School of Medicine

Indiana’s Funding Ban for Kinsey Sex-Research Institute Threatens … – The Chronicle of Higher Education

The decision to ban state funding for Indiana University at Bloomingtons famed sex-research institute threatens academic freedom and sets a troubling precedent for legislative interference in research nationwide, the universitys president, Pamela Whitten, said in a recent public statement. The ban, included in the state budget after a heated debate, was inspired by a conservative lawmakers unproven claims, based on decades of circulated rumors, that the Kinsey Institutes founder had promoted pedophilia and that the institute endangered children.

The state doesnt allocate any money directly for the institute, which receives the vast majority of its funding from grants and outside philanthropy, so the impact of this specific prohibition will be mostly administrative and symbolic. The state simply gives money to the university, which until now, it could spend on the institute.

The institute was founded in 1947 at the Bloomington campus as the Institute for Sex Research. Its founder, Alfred C. Kinsey, was an American biologist and professor of entomology and zoology who had been teaching a college course on marriage and was surprised by how little his students knew about sexuality. After founding the institute, he and his team collected and studied thousands of sexual histories. Kinsey, who died in 1956, rose to national prominence after the publication of his books Sexual Behavior in the Human Male in 1948 and Sexual Behavior in the Human Female in 1953.

In the former, he argued that human sexuality existed on a continuum from heterosexual to homosexual, and that people didnt neatly fit one or the other. Because Kinseys research included extensive interviews with at least one pedophile, his fiercest critics accused him of encouraging sexual deviancy. Others questioned his research methods and data.

In the second book, Kinsey examined the sex life of American women, which outraged many 1950s readers with its findings about the frequency of premarital sex and masturbation. Congressional critics accused the Rockefeller Foundation of contributing to the nations moral decay by funding the research. It stopped doing so in 1954, two years before Kinseys death.

Among the contemporary topics the institute studies are issues related to reproductive health, sexually transmitted disease, teen pregnancy, and sexual abuse. It also delves into relationships and dating. Researchers should be protected from interference with such work, the universitys president wrote in a prepared statement last month.

As a premier research institution with a 200-year legacy of impact within our state and around the world, IU is firmly committed to academic freedom, Whitten wrote. The university is concerned that a provision singling out a specific research institute sets a troubling precedent with implications that could limit the ability of public colleges and universities to pursue research and scholarship that benefits people and improves lives.

She went on to say that the university will conduct a thorough legal review to ensure it follows state law and added that its committed to the ongoing crucial research and robust scholarship conducted by IU faculty and the Kinsey Institute. In a letter to faculty and staff members, Whitten and other top campus administrators said the university will continue to support the institutes faculty in finding and securing the research grants and private philanthropic support that already make up the vast majority of its funding.

The budget signed by Eric J. Holcolm, Indianas Republican governor, specifically prohibits state money from being used to cover the institutes on-campus facilities, research work, utilities, office supplies, and maintenance of research photographs or films.

The stipulation banning state spending on the Kinsey Institutes work was introduced by Rep. Lorissa Sweet, a Republican from Wabash. She introduced it as an amendment to the proposed budget because of her objections to the institutes founder, whom she accused on the House floor of exploiting children through interviews with adults talking about how children experience orgasm. Sweet, who did not respond to requests for comment, also suggested that the institute continues to support sexual abusers, a claim that has never been proved.

On its website, the institute urged its supporters to take to social media and other channels to defend the right to conduct sex research. The budget restriction takes aim at the very foundation of academic freedom and stifles critical research on sexuality, gender, relationships, and reproduction, it said.

Since 1947, the Kinsey Institute has been an international thought leader in providing an unbiased and apolitical scientific approach to human sexuality, the website post said. In this time of divisive politics and the rise of disinformation, Kinsey Institute research, education, and historical preservation are more important than ever.

The university did not make the president or the institutes executive director, Justin R. Garcia, available for interviews, but it referred The Chronicle to an opinion piece published this week in The Washington Post thats also posted on the institutes website.

For generations, the Kinsey Institute has shone a light on diverse aspects of sex and sexuality, in pursuit of answers that bring us closer to understanding fundamental questions of human existence, Garcia, who is a senior scientist at the institute and also a professor of gender studies, wrote. Sweet, the lawmaker who introduced the budget amendment, had parroted false allegations of sexual predation in the institutes historical research and ongoing work, which the institute, the university, and outside experts have repeatedly refuted.

Rep. Matt Pierce, a Democrat whose Bloomington district includes the flagship campus, said, These same unproven allegations about Kinsey were circulating about 20 years ago. Really crazy stuff about Kinsey experimenting with children and babies that were circulating in these conservative culture-war stories. The reports were being recirculated because of a 1998 book by a conservative author, Judith A. Reisman, that accused Kinsey of shaking the nations moral foundation with dangerous research and exploitive experiments on children.

Pierce, who is also a senior lecturer in the universitys Media School, was among a group of state legislators who visited the institute to investigate and found that there was no evidence to back up their fellow lawmakers concerns that children were being exploited.

Because the author requested a roll call vote, that locked it in, Pierce said in an interview on Friday. The amendment passed 53 to 34. Hard-core Republicans who actually believed this stuff voted for it, but others who were fearful of being taken out in a Republican primary went along with it, figuring, Im not going to lose my seat over this. Sweet, the bills author, is a freshman who toppled a longtime moderate Republican incumbent, Pierce pointed out.

When Kinseys report on womens sexuality came out in the 1950s, Pierce said, it showed that women were more sexually active than people believed, and there was an explosion of moral panic Youre lying. This cant be true.

The same moral panic, he said, has been happening in Indiana around transgender people. The governor last month signed into law a ban on gender-affirming care for minors. Kinseys research about the fluidity of gender may have alarmed many of those same lawmakers who approved the ban, Pierce said.

He told his colleagues during a heated floor debate that, even if they believed what was being said about Kinsey, it was 50 to 70 years ago, and that today, federal laws and university policies protect research subjects.

While the ban on using state funds will force the university to go through time-consuming checks to be sure public money isnt going toward institute costs, To me, the greater concern is the precedent that the legislator is attempting to stamp out a whole area of academic inquiry, Pierce said. What will be next?

In his opinion piece in The Washington Post, Garcia described the institute as the leading sex-research institute in the world, staffed by internationally renowned biologists, psychologists, anthropologists, health scientists, and demographers. The institute, he wrote, publishes dozens of scientific and academic articles each year across a variety of disciplines. Its critics, over the decades, have painted a far different picture, blaming the research center for promoting homosexuality and pornography, inciting the sexual revolution, and tearing away at the nations moral fabric.

Garcia warned that Indiana isnt alone in seeing debates over gender and sexuality become politicized. Legislators elsewhere, he wrote, are ignoring scientific evidence in passing laws that restrict reproductive health care, discussions of gender identity, and basic sex education. Despite the latest setback, he wrote, I am optimistic that this latest culture war will pass. And the Kinsey Institute will carry on.

Go here to read the rest:
Indiana's Funding Ban for Kinsey Sex-Research Institute Threatens ... - The Chronicle of Higher Education

PET Nuclear Medicine Market By Applications ( Oncology, Cardiology, Neurology, Other PET Applications ) – openPR

PET Nuclear Medicine Market

Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00015978/?utm_source=OpenPR&utm_medium=10379

Key Players Analysis: Cardinal Health Curium GE Healthcare Lantheus Medical Imaging, Inc. Bayer AG Bracco Imaging S.P.A. Eczacibasi-Monrol Nuclear Products Nordion, Inc. (A Subsidiary of Sterigenics International) Advanced Accelerator Applications (AAA) (A Part of Novartis) NTP Radioisotopes Soc, LTD.

The report covers key developments in the PET Nuclear Medicine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from PET Nuclear Medicine market are anticipated to have lucrative growth opportunities in the future with the rising demand for PET Nuclear Medicine in the global market. Below mentioned is the list of few companies engaged in the PET Nuclear Medicine market.

Speak to Analyst @ https://www.theinsightpartners.com/speak-to-analyst/TIPRE00015978?utm_source=OpenPR&utm_medium=10379

Research report has been compiled by studying the market in-depth along with drivers, opportunities, restraints & other strategies as well as new-developments that can help a reader to understand the exact situation of the market along with the factors that can limit or hamper the market growth and the report also has been updated with Impacts & effects of Coronavirus pandemic and how it has influenced consumer behavior & the growth of the market as well as industries.

MARKET SEGMENTATIONThe PET nuclear medicine market is segmented on the basis of type and application. Based on type, the market is segmented as F-18, Rb-82, Other PET Isotopes. On the basis of application, the market is categorized as oncology, cardiology, neurology, and other pet applications.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the PET Nuclear Medicine Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The PET Nuclear Medicine Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

Get a Full Copy @ https://www.theinsightpartners.com/buy/TIPRE00015978/?utm_source=OpenPR&utm_medium=10379

Contact USContact Person : Sameer JoshiPhone : +1-646-491-9876E-mail : sales@theinsightpartners.com

About US

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Food and Beverages, Consumers and Goods, Chemicals and Materials.

This release was published on openPR.

See more here:

PET Nuclear Medicine Market By Applications ( Oncology, Cardiology, Neurology, Other PET Applications ) - openPR

Ask the Pediatrician: Why is it important to teach children about body … – Union Democrat

The statistics reported by the Rape, Abuse & Incest National Network are sobering: 1 in 3 girls and 1 in 20 boys will experience sexual abuse or sexual assault by the time they reach age 17.

The idea that anyone would sexually abuse a child is terrifying, especially for parents and caregivers. But like with any risk our children might face, we need to be able to empower them with information that will help them recognize unsafe situations.

Children and teens who feel in control of their bodies are less likely to fall prey to sexual abusers. And if they do suffer abuse, they are more likely to tell a trusted adult which can make all the difference in stopping the events and subsequently helping them recover from this painful experience.

Here are some tips to help parents teach their children about body boundaries and safety:

Use appropriate language. Teach children proper names for all body parts, including their genitals: penis, vagina, breasts and buttocks. Making up names for body parts may give the impression that they are bad or a secret and cannot be talked about. Also teach your child which parts are private. This includes the parts of their body that are covered by their swimsuit, as well as their mouth. These places should not be touched or looked at without their permission.

Evaluate your family's respect for modesty. Modesty isn't a concept most young children can fully grasp. But you can still lay a foundation for future discussions and model good social boundaries. If you have kids of various ages, for example, teach your younger children to give older siblings their privacy if they request it.

Don't force affection. Do not force or guilt your children to give hugs or kisses. It is OK for them to tell even grandma or grandpa that they do not want to give them a kiss or a hug goodbye. Teach your child alternate ways to show affection and respect without close physical touch (high-fives, thumbs-up, etc.) Reinforce that their body is theirs to control, a concept called body autonomy.

Explain OK vs. not-OK touches. An "OK touch" is a way for people to show they care for and help each other, like when caregivers help with bathing or toileting, or when doctors check to make sure their body is healthy. A "not OK touch" is one they don't like, hurts them, makes them feel uncomfortable, confused, scared or one that has anything to do with private parts.

Reinforce that people should respect each other. Discuss how it is never OK for anyone to look at or touch their private parts without their permission. At the same time, they should not look at or touch other people's bodies without their permission.

Give your children a solid rule about inappropriate touches. This will make it easier for them to recognize a not-OK touch if one happens and empower them to say no to these.

Remind your child to always tell you or another trusted grown-up if anyone ever touches their private parts or makes them feel uncomfortable in any way. Inappropriate touching especially by a trusted adult can be very confusing to a child. Reassure your children that you will listen to and believe them if they tell you about not-OK touches.

Control media exposure. Make a family media plan. Get to know the rating systems of video games, movies and television shows, and make use of parental controls available through many cellular, internet, cable and satellite providers. Providing appropriate alternatives is an important part of avoiding exposure to sexual content in the media. Be aware that children may see adult sexual behaviors in person or on screens and may not tell you that this has occurred.

Review this information regularly with your children. Some good times to talk to your children about personal safety are during bath time, bedtime, doctor visits and before any new situation. Children meet and interact with many different adults and children every day: at child care, sports practices, dance classes, camps and after-school programs, to name a few. Giving them tools to recognize and respond to uncomfortable situations is key.

Expect questions. The questions your child asks and the answers that are appropriate to give will depend on your child's age and ability to understand. It is always important to tell the truth.

Always let your child know you believe in them and will do everything you can to protect them from harm. Help them understand that they will not be in trouble for telling you about information that should not be kept secret. Empower them to tell another trusted adult if they are too uncomfortable telling you.

If you have any questions about ways to keep your child safe from harm, including sexual abuse, talk with your pediatrician.

More information is available at HealthyChildren.org.

ABOUT THE WRITER

Shalon Nienow, MD, FAAP, is a member of the American Academy of Pediatrics Council on Child Abuse and Neglect Executive Committee. She is division director of child abuse pediatrics at Rady Children's Hospital in San Diego. She also serves as medical director at the Chadwick Center for Children and Families and clinical director of child abuse pediatrics at UC San Diego School of Medicine. As a child abuse pediatrician, she provides medical evaluations for children who may have experienced any form of abuse or neglect.

2023 Tribune Content Agency, LLC.

Link:

Ask the Pediatrician: Why is it important to teach children about body ... - Union Democrat

Science-First Skincare Company Michal Morrison Secures Exclusive World-Wide License of Proprietary STEM6 Molecule, Supported by Over 25 Years of…

AUSTIN, Texas, May 4, 2023 /PRNewswire/ -- Science-first skincare companyMichal Morrison Inc., has officially received an exclusive world-wide license to use the revolutionary STEM6 molecular technology in skincare.

Michal Morrison

STEM6, a new superpower metamolecule , marks a new era of biomimetic skincare. A scientific breakthrough in the beauty industry, STEM6 is a new composition of matter that supports the skin's stem cell signaling pathway to awaken the millions of cells responsible for healthy-looking skin. As a result, skin is healthier, more radiant, and visibly rejuvenated.

Based on 25 years of stem cell science, the exclusive STEM6 technology was discovered by Dr. Fuqiang Ruan, an innovative scientist with a doctorate in Synthetic Organic Chemistry, and stem cell scientist Dr. Michael Kahn, Professor of Cancer Biology and Molecular Medicine at the Beckman Research Institute, City of Hope. Michal Morrison Inc. was founded by Austin-based entrepreneur Michal Ann Morrison. Michal's passion for a 'science first approach to skincare' became her inspiration to create a product with novel technology and unparalleled efficacy.

Genesis Molecular Technologies Inc., an affiliate organization of Michal Morrison Inc, received the notice of allowance (NOA) from the United States Patent and Trademark Office on March 7, 2023. The patent relates generally to modulation of the Wnt/-catenin pathway in mammalian cells and tissues, and more particularly to novel CREB binding protein (CBP)/-catenin inhibitors and the cosmetic, and therapeutic uses thereof (e.g., in dermatological applications for skin, hair and nails), and methods of making the disclosed exemplary compounds.

Michal Morrison's inaugural hero product, Genesis STEM6 Molecular Serum, is the first and only bioserum with the patented STEM6 molecule. This molecular superpower uses your biology's inherent potential to extend cell longevity for healthier-looking skin.

Story continues

The STEM6 molecule is exclusively available in Michal Morrison products. Genesis STEM6 Molecular Serum is available in a premium recyclable glass bottle onMichalMorrison.com for $175, or for $140 through a two-month subscription program.

For additional information and interview requests please contact:Creative Media Marketing at michalmorrison@cmmpr.com

ABOUT MICHAL MORRISON, INC.: Michal Morrison, Inc. is a science-first skincare company established in stem cell science and supported by its novel STEM6 molecular technology. Founded by Michal Morrison in 2022, the company will premiere the first and only bioserum with the STEM6 molecule - Genesis STEM6Molecular Serum. Michal Morrison products are available online atwww.michalmorrison.com.

Michal Morrison

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/science-first-skincare-company-michal-morrison-secures-exclusive-world-wide-license-of-proprietary-stem6-molecule-supported-by-over-25-years-of-research-in-stem-cell-science-301815541.html

SOURCE Michal Morrison

Continued here:

Science-First Skincare Company Michal Morrison Secures Exclusive World-Wide License of Proprietary STEM6 Molecule, Supported by Over 25 Years of...

Lab-grown fat could give cultured meat real flavor and texture – EurekAlert

Researchers have successfully bulk-produced fat tissue in the lab that has a similar texture and make-up to naturally occurring fats from animals.

The results, described in a study published today in eLife, could be applied to the production of cultured meat grown entirely from cells, giving it a more realistic texture and flavour.

Cultivated meat has been making waves in the news lately, with reports from startup companies around the world developing cell-grown chicken, beef, pork and fish mostly in early stages of development, not ready for large-scale production and with a couple of exceptions, not yet approved for commercial sale. Most of those products in development are in the form of an unstructured mixture of cells like chicken nuggets rather than a slice of chicken breast. What is lacking is the texture of real meat, created by muscle fibres, connective tissue and fat and its the fat that gives meat flavour.

In fact, consumer testing with natural beef of different fat content showed that the highest scores were registered for beef containing 36% fat.

However, producing cultured fat tissue in sufficient quantities has been a major challenge because, as the fat grows into a mass, the cells in the middle become starved of oxygen and nutrients. In nature, blood vessels and capillaries deliver oxygen and nutrients throughout the tissue. Researchers still have no way to replicate that vascular network at a large scale in lab grown tissue, so they can only grow muscle or fat to a few millimetres in size.

To get around this limitation, the researchers grew fat cells from mice and pigs first in a flat, two-dimensional layer, then harvested those cells and aggregated them into a three-dimensional mass with a binder such as alginate and mTG, which are both already used in some foods.

Our goal was to develop a relatively simple method of producing bulk fat. Since fat tissue is predominantly cells with few other structural components, we thought that aggregating the cells after growth would be sufficient to reproduce the taste, nutrition and texture profile of natural animal fat, says first author John Yuen Jr, a graduate student at the Tufts University Center for Cellular Architecture (TUCCA), Massachusetts, US. This can work when creating the tissue solely for food, since theres no requirement to keep the cells alive once we gather the fat in bulk.

The aggregated fat cells immediately had the appearance of fat tissue, but to see if they truly reproduced the features of native fat from animals, the team carried out a series of further experiments.

First, they explored the texture, by compressing the fat tissue and seeing how much pressure it could withstand compared to natural animal fat. They found that cell-grown fat bound with sodium alginate was able to withstand a similar amount of pressure to fat from livestock and poultry, but the cell-grown fat that was bound with mTG behaved more like rendered fat similar to lard or tallow. This suggests it could be possible to fine-tune the texture of cultured fat, so it best resembles the real-life texture of fat within meat, using different types and amounts of binders.

Cooking releases hundreds of compounds that add flavour to the meat, and most of those compounds originate from fat, including lipids and their component fatty acids. The team therefore examined the composition of molecules from the cell-grown fat and found that the mix of fatty acids from cultured mouse fat differed from native mouse fat. However, the cultured pig fat had a much closer fatty acid profile to the native tissue. The teams preliminary research suggests it might be possible to supplement growing fat cells with the required lipids to ensure that they more closely match the composition of natural meat.

This method of aggregating cultured fat cells with binding agents can be translated to large-scale production of cultured fat tissue in bioreactors a key obstacle in the development of cultured meat, says senior author David Kaplan, Stern Family professor of Biomedical Engineering at Tufts University and director of TUCCA. We continue to look at every aspect of cultured meat production with an eye toward enabling mass production of meat that looks, tastes and feels like the real thing.

##

Media contacts

Emily Packer, Media Relations Manager

eLife

e.packer@elifesciences.org

+44 (0)1223 855373

George Litchfield, Marketing and PR Assistant

eLife

g.litchfield@elifesciences.org

About eLife

eLife transforms research communication to create a future where a diverse, global community of scientists and researchers produces open and trusted results for the benefit of all. Independent, not-for-profit and supported by funders, we improve the way science is practised and shared. In support of our goal, weve launched a new publishing model that ends the accept/reject decision after peer review. Instead, papers invited for review will be published as a Reviewed Preprint that contains public peer reviews and an eLife assessment. We also continue to publish research that was accepted after peer review as part of our traditional process. eLife receives financial support and strategic guidance from the Howard Hughes Medical Institute, Knut and Alice Wallenberg Foundation, the Max Planck Society and Wellcome. Learn more at https://elifesciences.org/about.

To read the latest Cell Biology research in eLife, visit https://elifesciences.org/subjects/cell-biology.

And for the latest in Stem Cells and Regenerative Medicine, see https://elifesciences.org/subjects/stem-cells-regenerative-medicine.

Aggregating in vitro-grown adipocytes to produce macroscale cell-cultured fat tissue with tunable lipid compositions for food applications

4-Apr-2023

No competing interests declared

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

See the original post here:
Lab-grown fat could give cultured meat real flavor and texture - EurekAlert

Meet the 2023 Outstanding Graduating Students – UMaine News … – University of Maine

Twelve undergraduates have been named 2023 Outstanding Graduating Students at the University of Maine. Read their short biographies:

Mille Baartvedt of Oslo, Norway is the Outstanding Graduating International Student in the College of Education and Human Development. The kinesiology and physical education major is a Presidential Scholar. On campus, she has worked at the New Balance Student Recreation Center and as a teaching assistant, and been a member of the Maine chapter of Pi Beta Phi and the Womens Soccer Club. Baartvedt did her student teaching at Hampden Academy and Orono Middle School. She will pursue a graduate degree in sports management at Boston College, and plans a career as an educator and athletic director.

A full Q&A with Baartvedtis online.

Samantha Costanza from Norwalk, Connecticut is the Outstanding Graduating Student in the Division of Lifelong Learning. Costanza is a university studies major in the labor studies track, and an Online Flagship Scholarship recipient. Costanza has worked full-time as a communications professional for a national retirement company while pursuing an associate degree at a local community college, then transferring to UMaine. Her research as part of her academic work included how COVID impacted the union construction industry; how the legalization of marijuana has changed the landscape of workplace drug testing; and the pay gap and working conditions for women in many industries. Beyond her coursework, Costanza is active in her community choir. She plans to continue her now 23-year career with Transamerica.

A full Q&A with Costanza is online.

Emily Davison of North Waterboro, Maine is the Outstanding Graduating Student in the College of Education and Human Development. She is majoring in athletic training with a minor in child development and family relations. The UMaine Presidential Scholarship recipient also received the 2023 Eastern Athletic Trainers Association Joseph Abraham Scholarship and 2022 Maine Athletic Trainers Association Wes Jordan Scholarship. Davison did her athletic training internship this spring at Foxcroft Academy and has had numerous athletic training clinical experiences with athletics teams at UMaine, Husson University and Hampden Academy. On campus, she also worked in the UMaine Ticket Office. Davison plans to pursue a masters degree in sport management at the University of Central Arkansas while working full time as a high school athletic trainer. Her goal is to be an athletic director at a class AA high school in southern Maine.

A full Q&A with Davison is online.

Kell Fremouw of Orono, Maine is the Outstanding Graduating Student in the College of Engineering. The Honors College student is majoring in engineering physics, with a concentration in mechanical engineering and a minor in mathematics. Last summer, he was awarded a National Science Foundation Undergraduate Research Fellowship in Sensor Science and Engineering, and he has worked as a teaching assistant in physics. His honors thesis is: Thermal Stability of Platinum-Silicon Alloy Films Grown on Langasite Substrates for Use in Microwave Acoustic Sensor Technology. Fremouw has been a student researcher examining optical microscopy data in the laboratory of professor Samuel Hess and modeling graphene transistors in the laboratory of professor Sheila Edalatpour. In addition, Fremouw worked on a materials science project with professor Robert Lad. He also participates in STEM outreach with the Society of Physics Students. Fremouw is a competitive kayaker and canoeist who qualified in the U.S. trials for the Wildwater Canoeing World Championships. He has been awarded a Deans Fellowship for Excellence at the University of Colorado Boulder where he will pursue a Ph.D. in materials science and engineering. He plans to work in academia or in a lab on improving sustainable energy production and energy efficiency.

A full Q&A with Fremouw is online.

Anna Kahelin of Helsinki, Finland is the Outstanding Graduating International Student in the Maine Business School. She is a business administration major in management with a minor in psychology, and member of the Womens Basketball team. Kahelin received an America East Elite 18 award, and was a member of Team Maine from 202122. She plans to pursue an MBA at UMaine and play basketball for another year.

A full Q&A with Kahelin is online.

Abigail Mulligan of Thunder Bay, Ontario, Canada is the Outstanding Graduating International Student in the College of Liberal Arts and Sciences. Mulligan is an Honors College student triple-majoring in chemistry with a pre-med concentration; in food science and human nutrition, with a concentration in dietetics; and in zoology. She is minoring in psychology, sustainable food systems and neuroscience. Among her numerous honors is the Charles A. Brautlecht Scholarship, the S.P. Livermore Award, and the Dr. Melanie Gershman-Tewksbury 77 Scholarship. Her honors thesis is: The Development of Sustainable, Flax-Integrated, Plastic Composite. Mulligan has been a student researcher in professor William Gramlichs laboratory, studying the development of sustainable, flax-integrated biocomposites. She is president of the Nutrition Club, secretary of the UMaine chapter of Kappa Omicron Nu and a 4-H STEM Ambassador. Mulligan also has been a member of the UMaine Swimming and Diving team and was a peer tutor. She plans to attend medical school to pursue a career in pediatric neurosurgery.

A full Q&A with Mulligan is online.

Theophile Nkulikiyinka of Kigali, Rwanda is the Outstanding Graduating International Student in the College of Engineering. Nkulikiyinka, a biomedical engineering student, is a Presidential Scholar and the recipient of the International Presidential Scholarship. He has been an undergraduate researcher in the laboratory of professor Michael Mason, evaluating the potential of cellulose nanofiber as a biomaterial for bone replacement. His academic experiences off campus included shadowing at Hanger Orthotics and Prosthetics Clinic, and working as a cardiac technician at Northern Light Health and a direct support professional for adults with disabilities at MERT Enterprises and Peace Residential Care. Nkulikiyinka is president of UMaines African Student Association. He plans to pursue a masters degree in prosthetics and orthotics at the University of Hartford.

A full Q&A with Nkulikiyinka is online.

Shelby Philips of Buffalo, New York is the Outstanding Graduating Student in the Maine Business School. Philips is a business administration major in management. Her numerous academic awards include the Senior Alumni Non-Traditional Student Scholarship, the Carville Non-Traditional Student Scholarship, and David and Debra Scott Scholarship. Philips interned with Food Rescue Maine, an initiative of the Senator George J. Mitchell Center for Sustainability Solutions, and served as president of MBS Corps. She also was a member of SPIFFY and the International Business and Culture Club, and was a cast member in the School of Performing Arts production of Everybody. This summer, she will be a producer on an independent feature film. Philips plans to pursue a career in management.

A full Q&A with Philips is online.

Aiden Pike of Searsmont, Maine is the Outstanding Graduating Student in the College of Natural Sciences, Forestry, and Agriculture. He is a double major in biochemistry, and molecular and cellular biology, with minors in French and chemistry. The Honors College student, who will receive two bachelors degrees, also is in the 4+1 masters bioinformatics program with the Roux institute at Northeastern University. His numerous academic honors include a Visual and Performing Arts Scholarship, the Professor Frederick H. Radke Award and the Honors INBRE Thesis Fellowships in Comparative Functional Genomics. His honors thesis is: The Role of Calmodulin-Dependent Protein Kinase IV in Regulating JC Polyomavirus Infection. Pike has been a student researcher in professor Melissa Maginnis laboratory, studying how the immune response is implicated in JC polyomavirus infection and the signaling mechanisms that the virus may take advantage of to gain control of the host cell. He also spent a summer as a research fellow at MDI Biological Laboratory. On campus, Pike has been a teaching assistant and a course facilitator, and a member of the Pride of Maine Black Bear Marching Band and the Concert Band. With the completion of his masters degree, Pike plans to apply to an M.D./Ph.D. program to study infectious diseases and practice translational medicine.

A full Q&A with Pike is online.

Elaine Thomas of Hampden, Maine is the Outstanding Graduating Student in the Honors College. She is a business administration major in management with a minor in music. The Honors College student received the 2022 John M. Rezendes Ethics Award for her first-place essay: When We Cannot Care for Ourselves: Ethics, Interdependence, and the Moral Danger of the Self-Care Message. Also in 2022, she received the Maine Campus Compact PILLARS (Philanthropy, Innovation, Learning, Leadership, Action, Responsibility, and Service) Award and participated in the Maine NEW (National Education for Women) Leadership program. Her honors thesis is: Evidence-based Family Strengthening Training in Maine: A Resource Assessment and Proposal to Reduce Barriers and Increase Facilitators. Throughout her time at UMaine, Thomas has been a member of the Attachment Theory Team of the Honors College Servant Heart Research Collaborative. She also has interned with three nonprofit organizations: Heart of Maine United Way, Partners for Peace and the American Red Cross, and donates her time to Literacy Volunteers of Bangor. Thomas plans to work for a nonprofit organization in Maine.

A full Q&A with Thomas is online.

Maria Vina Lopez of Santiago de Compostela, Spain is the Outstanding Graduating International Student in the College of Natural Sciences, Forestry, and Agriculture, and in the Honors College. The biology major with a minor in mathematics is the recipient of numerous awards, including the International Presidential Scholarship and a Center for Undergraduate Research Fellowship. Her honors thesis is: An Organoid Model for Human Brain Aging. As a student researcher, Vina Lopez studied the drug synergy effect of fluconazole and cyclosporine A on Candida albicans in the laboratory of professor Robert Wheeler, and used C. elegans to study the effect of novel small molecule combinations on age reversal in vivo and identify life span-extending cocktails in professor Suzanne Angelis lab. For two summers, she also was a research intern in the microbiology laboratory of professor Darren Higgins at Harvard Medical School, and for eight months last year, collaborated on her honors research in the genetics laboratory of professor David Sinclair, also at Harvard Medical School. At UMaine, Vina Lopez has been president of Engineers Without Borders, a resident assistant, a Maine Learning Assistant and peer tutor in genetics, and a member of the University Volunteer Ambulance Corps. She plans to pursue a Ph.D. in biological and biomedical sciences at Harvard Medical School.

A full Q&A with Vina Lopez is online.

Willow Wind of Rumford, Maine is the Outstanding Graduating Student in the College of Liberal Arts and Sciences. The Honors College student is a communication major with minors in media studies and Spanish. Her academic honors include a McGillicuddy Humanities Center Fellowship and James S. Stevens Outstanding Junior Award, both in 2022, and a 2021 Center for Undergraduate Research Fellowship Award and first-place recognition the Communication and Journalism Showcase for her research project: Communication Goals and Practices of Trans- and Gender Non-conforming (TGNC) Individuals and Their Impact on Mental Health. Her Honors thesis is: Conceptualizing and Enacting Gender Euphoria: Exploring Awareness and Action Across Gender Demographics. Wind has conducted research in collaboration with professor Liliana Herakova, focused on trans and gender-nonconforming communication and mental health, and as a research assistant in the Media Psychology Lab of professor Amelia Couture Bue, working on a project exploring the desirability of STEM to college women. She also has been active in the Scholars Strategy Network, Progressive Pipeline, and Partners for Peace, and in a UMaine collaborative effort to improve classroom belonging. Wind plans to pursue nonprofit advocacy work and a masters degree.

A full Q&A with Wind is online.

Contact: Margaret Nagle, nagle@maine.edu

Link:
Meet the 2023 Outstanding Graduating Students - UMaine News ... - University of Maine